Table 4.
Data sets | All-cause mortality | Cause of death | T2DM-related events* | Cardiac events* | Vascular events* | Liver disease | Ageing diseases |
Depression | |||||||||
T2DM | Renal failure† | Neuropathy‡ | Retinopathy | CVD | Angina | CAD | CHF | MI | PCI/CABG | Hypertension | Stroke/TIA | ||||||
ACCORD | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||
AFFIRM | + | + | + | + | + | + | + | + | |||||||||
BARI 2D | + | + | + | + | + | + | + | + | + | + | + | + | + | ||||
ARIC | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
JHS | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||
FHS cohort | + | + | + | + | + | +§ | + | + | + | + | + | + | + | + | + | + | |
FHS offspring | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | |
FHS Gen3 | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | |
FOCUS | + | + | + | + | + | + | |||||||||||
MRFIT | + | + | + | + | + | + | + | + | + | + | + | + | + | + | |||
ALLHAT | + | + | + | + | + | + | + | + | + | + | + | + | |||||
BHS | + | + | + | + | + | + | |||||||||||
CORAL | + | + | + | + | + | + | + | + | + | + | + | + | |||||
NGHS | + | + | + | ||||||||||||||
OMNI heart | + | + | + | ||||||||||||||
POWER-UP | + | + | + | + | + | + | + | + | + | + | + | + | |||||
SPRINT-POP | + | + | + | + | + | + | + | + | + |
Ageing diseases=dementia, Alzheimer’s or Parkinson’s.
*All events include both fatal and non-fatal.
†Based on serum potassium and creatinine levels, and need for dialysis.
‡Based on amputations.
§Only 1973–1975.
ACCORD, Action to Control Cardiovascular Risk in Diabetes; AFFIRM, Atrial Fibrillation Follow-Up Investigation of Rhythm Management; ALLHAT, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial; ARIC, Atherosclerosis Risk in Communities; BARI 2D, Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes; BHS, Bogalusa Heart Study; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CHF, congestive heart failure; CORAL, Cardiovascular Outcomes in Renal Atherosclerotic Lesions; CVD, cardiovascular disease; FHS, Framingham Heart Study; FOCUS, Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair; JHS, Jackson Heart Study; MI, myocardial infarction; MRFIT, Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease; NGHS, NHLBI Growth and Health Study; OMNI heart, Optimal Macronutrient Intake Trial to Prevent Heart Disease; PCI, percutaneous coronary intervention; POWER-UP, Practice Based Opportunities for Weight Reduction Trial at the University of Pennsylvania; SPRINT-POP, Systolic Blood Pressure Intervention Trial Primary Outcome Paper; TIA, transient ischaemic attack; T2DM, type 2 diabetes mellitus.